Stocks finished the week on the plus side, as the Dow hit a new high, and the broader market held its own against more bearish investors who are arguing more forcefully that the long bull market has to come to an end at some point. Several stocks helped to build some excitement for market participants, and Clean Energy Fuels (NASDAQ: CLNE ) , Universal Display (NASDAQ: OLED ) , and Nuverra Environmental Solutions (NYSE: NES ) were among the best-performing stocks in the market Friday.
Source: Clean Energy Fuels.
Clean Energy Fuels jumped 12% as the natural-gas fueling station network operator reported much better conditions in its business than investors had expected. A 24% jump in gallons delivered helped reverse sluggishness in earlier quarters, and even though gains in dollar-value revenue were limited, adjusted sales soared 43% once you take out one-time items from the previous year. The expiration of crucial tax credits had a big impact on Clean Energy Fuels' income statement, reversing a year-ago profit, and raising questions about whether the company can get back to break-even levels quickly. For now, though, investors seem satisfied with Clean Energy Fuels' strategy to emphasize rising volume and station expansion.
Hot Prefered Stocks To Own For 2015: Biodel Inc (BIOD)
Biodel Inc. (Biodel), incorporated on December 3, 2003, is a development-stage speciality biopharmaceutical company focused on the development and commercialization of treatments for diabetes. The Company develops its product candidates by applying its formulation technologies to existing drugs. Its advanced program involves developing formulations of injectable recombinant human insulin (RHI). In addition to its ultra-rapid-acting insulin formulations, the Company has developed prototype formulations of a liquid glucagon, a basal insulin and a glucose responsive insulin, in each case for use by patients with diabetes. RHI-based formulation known as Linjeta was the subject of a New Drug Application (NDA).
The Company has two pivotal Phase III clinical trials with its preferred commercial formulation of Linjeta prior to re-submitting the NDA. In August 2011, it completed patient visits and analyzed top-line data from the first Phase 1 clinical trial of two RHI-based formulations. The trial was a single-center, randomized, double-blind, three-period crossover trial in 18 subjects with Type 1 diabetes. The purpose of the trial was to evaluate the pharmacokinetic and pharmacodynamic characteristics and injection site toleration of BIOD-105 and BIOD-107, as compared to the insulin analog marketed as Humalog. The Company conducted Phase I, Phase II and Phase III clinical trials comparing the performance of its Linjeta formulation of RHI to either Humulin, which is a branded formulation of RHI or Humalog. Its pivotal Phase III clinical trials were open-label, parallel group, randomized trials conducted at centers in the United States, Germany and India.
The Company competes with Eli Lilly, Novo Nordisk, Sanofi-Aventis, Halozyme Therapeutics, Inc. and MannKind Corporation.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 specialty biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Biodel (BIOD), which is focused on the development and commercialization of innovative treatments for diabetes. This stock has been hit hard by the bears over the last three months, with shares down by 24%.
If you take a look at the chart for Biodel, you'll notice that this stock is ripping higher here right off its 50-day moving average of $2.32 a share with strong upside volume. Volume on Thursday has so far registered over 750,000 shares, which is well above its three-month average action of 445,084 shares. This move is quickly pushing shares of BIOD within range of triggering a big breakout trade.
Traders should now look for long-biased trades in BIOD if it manages to break out above some near-term overhead resistance levels at $2.52 to $2.60 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 445,084 shares. If that breakout triggers soon, then BIOD will set up to re-test or possibly take out its next major overhead resistance levels $3 to its 200-day moving average of $3.39 a share. Any high-volume move above $3.39 will then give BIOD a chance to tag $4 a share.
Traders can look to buy BIOD off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $2.10 a share. One can also buy BIOD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
10 Best Rising Stocks To Invest In Right Now: Matthews International Corporation(MATW)
Matthews International Corporation designs, manufactures, and markets memorialization products and brand solutions for the cemetery and funeral home industries in the United States, Mexico, Canada, Europe, Australia, and Asia. The company's Bronze segment offers cast bronze memorials and other memorialization products; and cast and etched architectural products, as well as builds mausoleums. Its Casket segment provides wood and metal caskets; and casket components, such as stamped metal parts, metal locking mechanisms for gasketed metal caskets, adjustable beds, interior panels, and plastic ornamental hardware, as well as provides assortment planning and merchandising, and display products to funeral service businesses. The company's Cremation segment offers cremation equipment; cremation caskets; equipment service and supplies; and cremation urns and memorial products, as well as offers environmental systems; crematory operations and management services; and cremation col umbarium and niche units. Its Graphics Imaging segment provides brand management, pre-press services, printing plates, gravure cylinders, steel bases, embossing tools, special purpose machinery, engineering and print process assistance, print production management, digital asset management, content management, and package design services. The company's Marking Products segment offers a range of marking and coding products and related consumables, and industrial automation products for identifying, tracking, and conveying consumer and industrial products, components, and packaging containers. Its Merchandising Solutions segment provides merchandising displays and systems, such as permanent and temporary displays, custom store fixtures, brand concept shops, interactive kiosks, custom packaging, and screen and digitally printed promotional signage; and offers design and engineering services. The company was founded in 1850 and is based in Pittsburgh, Pennsylvania.
Advisors' Opinion:- [By Dan Caplinger]
The first thing to realize about StoneMor is that arcane and flexible accounting rules make it important to dig beneath its GAAP earnings. Growth throughout the industry has been substantial, as up-and-coming Carriage Services (NYSE: CSV ) continued to stay on pace for double-digit sales growth as it rapidly expands its reach. Even well-established player Matthews International (NASDAQ: MATW ) managed to grow revenue by nearly 14% in the quarter that ended in March, although its earnings fell slightly from the year-ago quarter. Still, StoneMor's sales haven't been able to rise as quickly as its peers, with its previous report including just a 6% gain in revenue.
10 Best Rising Stocks To Invest In Right Now: Rex Trueform Clothing Company Ltd (RTO)
Rex Trueform Clothing Company Limited is a South Africa-based company engaged in the manufacturing and marketing of clothing. The Company operates under two segments: Retail segment, the Company, through its ownership of Queenspark Limited, which operates a nationwide chain of Queenspark and J CREW stores, has a interest in the retailing of men�� and women�� clothing and related accessories. Through Property segment, Rex Trueform and its subsidiary have a direct investment in a portfolio of properties located in and around Cape Town. These properties are held either for the purpose of operations or for investment purposes. As of June 30, 2012, the Company operated 55 stores. In September 2012, the Company launched its newest brand Cath.Nic, a new fashion label exclusive to Queenspark. During the fiscal year ended June 30, 2012, the Company opened three new stores. Advisors' Opinion:- [By Corinne Gretler]
Rentokil Initial Plc (RTO) climbed 3.1 percent to 106 pence as Bank of America Corp. upgraded the U.K. pest-control and hygiene-services company to buy from neutral. The brokerage predicted that cash flow will improve in 2014 and 2015.
- [By Sofia Horta e Costa]
Rentokil Initial Plc (RTO) rose the most in almost eight weeks after a report that private-equity investor Clayton Dubilier & Rice LLC is considering combining the company�� office-maintenance unit with that of Balfour Beatty Plc. Cobham Plc dropped 4.6 percent as a shareholder sold a 3.6 percent stake in the maker of defense and aerospace equipment.
10 Best Rising Stocks To Invest In Right Now: J. W. Mays Inc.(MAYS)
J.W. Mays, Inc. owns and operates commercial real estate properties in the United States. Its properties are located in Brooklyn, Jamaica, Levittown, Massapequa, and Fishkill, New York, as well as in Circleville, Ohio. The company was founded in 1924 and is based in Brooklyn, New York.
Advisors' Opinion:- [By Geoff Gannon] is trading around book value your next step is to figure out how book value is calculated.
The reason a company trading below book value is interesting has to do with accounting. In the U.S., you don�� mark up the book value of land and many other potentially valuable assets just because you have evidence ��like an appraisal, comparable sale, etc. ��that the market value is now higher than your original cost.
So, there will be situations where knowing how a company accounts for its assets and knowing the stock trades for less than book value can help direct you to companies selling for less than they are worth.
DreamWorks is a movie studio. So it is using a rather subjective estimate of the ultimate revenue a movie will produce. It is then amortizing the cost of the movie as revenue comes in to the company in proportion to the percentage of revenue this represents relative to expected total revenue the movie will produce.
For very old movies, it�� actually a little different. And for flops it�� different. DreamWorks can write off flops. And it can�� expect the ultimate revenue for a movie to be higher to the extent such revenue comes more than 10 years after the film�� release.
In other words, DreamWorks has to fully amortize a movie within 10 years and disregard the value an 11-year-old movie might have.
This is explained in a note to the company�� 10-K. It is very important for Ben Graham-type investors to read all these notes carefully ��but especially the notes on depreciation and amortization:
Once a film, television special/series or live performance is released, capitalized productions costs are amortized and participations and residual costs are accrued on an individual title basis in the proportion that the revenue during the period for each title (��urrent Revenue�� bears to the estimated remaining total revenue to be recognized from all sources for each title (��ltimate Revenue��. The amo
10 Best Rising Stocks To Invest In Right Now: Zale Corp (ZLC)
Zale Corporation, incorporated on April 26, 1991, through its wholly owned subsidiaries, is a retailer of fine jewelry in North America. The Company operates in three segments: fine jewelry, kiosk jewelry and all other. As of July 31, 2012, the Company operated 1,124 specialty retail jewelry stores and 654 kiosks located mainly in shopping malls throughout the United States, Canada and Puerto Rico. The Company�� fine jewelry segment consists of five brands: Zales Jewelers, Peoples Jewellers, Zales Outlet, Mappins Jewellers, and Gordon's Jewelers The Company�� kiosk jewelry operates under the brand names Piercing Pagoda, Plumb Gold, and Silver and Gold Connection (collectively, Piercing Pagoda) through mall-based kiosks. The Company provides insurance and reinsurance services for various types of insurance coverage, which is marketed primarily to its private label credit card guests, through Zale Indemnity Company, Zale Life Insurance Company and Jewel Re-Insurance Ltd.
Fine Jewelry
Each brand specializes in fine jewelry and watches, with merchandise and marketing emphasis focused on diamond products. Zales Jewelers is the Company's national brand in the United States providing moderately priced jewelry to a range of guests. Zales Outlet operates in outlet malls and neighborhood power centers and capitalizes on Zales Jewelers' national advertising and brand recognition. Gordon's Jewelers is a value-oriented regional jeweler. Peoples Jewellers, Canada's fine jewelry retailer, provides guests with shopping experience. Mappins Jewellers offers Canadian guests a selection of merchandise from engagement rings to fashionable and contemporary fine jewelry.
The Company has extended its reach of certain brands through the use of its Webstores, mobile devices and social media to provide its guests access to its brands wherever and whenever they choose. In addition, the Company offers its guests the option to purchase warranty coverage on substantially all of its mercha! ndise in Fine Jewelry. The Company also offers repair services to guests who do not purchase warranty coverage. Zales Jewelers (Zales), the Company's United States based flagship, is a brand name in jewelry retailing in the United States, operating 639 stores in 50 states and Puerto Rico with an average store size of 1,681 square feet. Gordon's Jewelers (Gordon's) operates 147 stores in 27 states and Puerto Rico with an average store size of 1,534 square feet.
The Company�� Zales brand is positioned as the Diamond Store emphasizing on diamond jewelry, especially in the bridal and fashion segments. Zales and Gordon's combined revenues accounted for 60% of the Company's total revenues during the fiscal year ended July 31, 2012 (fiscal 2012). Both brands operate as multi-channel retailers and serve Internet guests through the e-commerce sites www.zales.com and www.gordonsjewelers.com, which accounted for approximately 5% of the Company's total revenues in fiscal 2012.
In Canada, the Company operates 206stores in nine provinces. The Company's Canadian operations consist of two brands, Peoples Jewellers (Peoples) and Mappins Jewellers (Mappins), and accounted for 17% of the Company's total revenues in fiscal 2012. The average store size is 1,605 square feet with an average transaction value of $332 in fiscal year 2012. Peoples serves Internet guests through the e-commerce site, www.peoplesjewellers.com. The Company operates 132 Zales Outlet (Outlet) stores in 35 states and Puerto Rico, sales from which accounted for 10% of its total revenues in fiscal 2012. The average store size is 2,362 square feet in fiscal 2012.
Kiosk Jewelry
The Company�� kiosk jewelry segment is focused on the opening price point jewelry guest. The Company's presence in Kiosk Jewelry has been expanded through the e-commerce site, www.pagoda.com. The Company also offers its guests the option to purchase warranty coverage on certain products. As of July 31, 2012, Piercing Pagoda op! erated 65! 4 locations in 41 states and Puerto Rico, sales from which accounted for 13% of the Company's total revenues in fiscal. Piercing Pagoda offers collection of bracelets, earrings, charms, rings, non-precious metal products and 14 karat and 10 karat gold chains, as well as a selection of silver and diamond jewelry, all in basic styles at moderate prices. Kiosk locations average 188 square feet in size in fiscal 2012.
All Other
The Company insurance companies are the insurers (either through direct written or reinsurance contracts) of the Company's guests' credit insurance coverage. In addition to providing merchandise replacement coverage for certain perils, credit insurance coverage provides protection to the creditor and cardholder for losses associated with the disability, involuntary unemployment, leave of absence or death of the cardholder. Zale Life Insurance Company also provides group life insurance coverage for the Company's eligible employees. In fiscal year 2012, 36% of the Company's private label credit card purchasers purchased some form of credit insurance. In fiscal year 2012, all other accounted for approximately 1% of the Company's total revenues.
The Company competes with Wal-Mart Stores, Inc., .C. Penney Company, Inc., Signet Jewelers Limited, and QVC, Inc.
Advisors' Opinion:- [By Paul Ausick]
Big earnings movers: Tivo Inc. (NASDAQ: TIVO) is up 5.6% at $11.58 following an earnings beat and improved guidance. Specialty retailer Express Inc. (NASDAQ: EXPR) is up 6.5% at $21.09 following results that met expectations (a rarity in retailing this quarter). Joy Global Inc. (NYSE: JOY) is down 4.7% at $48.89 after the mining equipment maker reported inline earnings and maintained a soft forecast. Zale Corp. (NYSE: ZLC) is up 29.8% at $11.63 after beating estimates and setting a new high of $11.69.
- [By Dan Moskowitz]
Zale (NYSE: ZLC ) is a specialty retailer of fine jewelry that has 1064 stores and 630 kiosks across North America. If you have ever walked through a mall, then you're familiar with the name Zale. With strong brand name recognition and the company swinging to a profit in fiscal-year 2013, you would think Zale should present a quality investment opportunity. While this is a possibility, there are several reasons why one much larger jewelry company should present a better long-term investment opportunity.
- [By Roberto Pedone]
Zale (ZLC) is a specialty retailer of fine jewelry in North America. This stock closed up 2.5% to $9.52 in Thursday's trading session.
Thursday's Range: $9.29-$9.56
52-Week Range: $2.94-$9.85
Thursday's Volume: 567,000
Three-Month Average Volume: 951,295From a technical perspective, ZLC bounced modestly higher here right above its 50-day moving average of $8.70 with lighter-than-average volume. This stock has been consolidating and trending sideways over the last month, with shares moving between $8.44 on the downside and $9.70 on the upside. This spike today is now starting to push ZLC within range of triggering a major breakout trade above the upper-end of its recent sideways trading chart pattern. That trade will hit if ZLC manages to take out some near-term overhead resistance levels at $9.70 to its 52-week high at $9.85 with high volume.
Traders should now look for long-biased trades in ZLC as long as it's trending above its 50-day at $8.70 or above more support at $8.44 and then once it sustains a move or close above those breakout levels with volume that hits near or above 951,295 shares. If that breakout triggers soon, then ZLC will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $12 to $14.
- [By Jake L'Ecuyer]
Top Headline
Signet Jewelers (NYSE: SIG) announced its plans to buy Zale (NYSE: ZLC) for around $690 million. Signet will pay $21 per share to acquire Zale, representing a 41% premium to Zale's closing price of $14.91 on Tuesday.
10 Best Rising Stocks To Invest In Right Now: Cambridge Heart Inc (CAMH)
Cambridge Heart, Inc., incorporated on January 16, 1990, is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. The Company's products incorporate its technology for the measurement of Microvolt T-Wave Alternans (MTWA). The MTWA Test is conducted by elevating the patient's heart rate through exercise as performed on a treadmill similar to a stress test, pharmacologic agents, or pacing with electrical pulses.
The Company's products, including its first generation HearTwave System and second generation HearTwave II System, CH 2000 Cardiac Stress Test System, MTWA original equipment manufacturer (OEM) Module (MTWA Module) and Micro-V Alternans Sensors have received 510(k) clearance from the United States Food and Drug Administration (FDA) for sale in the United States. The Company's products have also received the Conformite Europeenne (CE) mark for sale in Europe. The Company's first generation HearTwave System, CH 2000 Cardiac Stress Test System and the HearTwave II System have been approved for sale by the Japanese Ministry of Health Labor and Welfare.
The Company's 510(k) clearance allows the Company's MTWA Test to be used to test patients with known, suspected, or at risk of ventricular tachyarrhythmia and/or sudden cardiac arrest, and allows the claim that its MTWA Test is predictive of those events. The MTWA Module is designed to work with existing cardiac stress test platforms distributed by other manufacturers as an add-on module to enable MTWA testing to be performed using the Company's Micro-V Alternans Sensors.
The Company's HearTwave II System, which has replaced the Company's original HearTwave System, is used to perform both MTWA testing and standard cardiac stress testing. In addition to MTWA measurement, the Company's HearTwave II System is a cardiac diagnostic system designed to support a range of customized protocols for the conduct of cardiac exercise stress testing. The Comp! any's Micro-V Alternans Sensors are single patient use, multi-segment electrodes. The Company's CH2000 is a cardiac diagnostic system designed to support a range of customized protocols for the conduct and measurement of cardiac exercise stress testing.
The Company competes with GE Medical Systems.
Advisors' Opinion:- [By Peter Graham]
Last Friday, small cap stocks Cambridge Heart, Inc (OTCMKTS: CAMH), Abby Inc (OTCMKTS: ABBY) and Grillit Inc (OTCMKTS: GRLT) surged 176.92%, 71.2% and 24.07%, respectively. Of course, that was last week and today is a new trading week. So what should investors and traders alike be prepared for this week with these three small caps? Here is a closer look to help you decide on an investing or trading strategy:
Cambridge Heart, Inc (OTCMKTS: CAMH) Recently Changed Its BoardSmall cap Cambridge Heart, Inc is a healthcare company engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. On Friday, Cambridge Heart, Inc surged 176.92% to $0.018 for a market cap of $1.80 million plus CAMH is up 20% since the start of the year and down 86.1% over the past five years according to Google Finance.
10 Best Rising Stocks To Invest In Right Now: Life Technologies Corporation(LIFE)
Life Technologies Corporation operates as a global life sciences company. The company?s Molecular Biology Systems division offers molecular biology-based technologies, including basic and real-time PCR, RNA interference, DNA synthesis, sample preparation, transfection, cloning and protein expression profiling, protein analysis, and thermo-cycler instrumentation technologies. Its Cell Systems division provides cell culture media and sera, stem cells and related tools, cellular imaging products, antibodies, drug discovery services, and cell therapy related products used in the study of cell function. The company?s Genetic Systems division offers capillary electrophoresis systems and reagents, and next generation sequencing systems and reagents comprising SOLiD and Ion Torrent systems, as well as reagent kits developed specifically for applied markets, such as forensics and food safety, pharmaceutical quality monitoring, and animal health markets. Life Technologies Corporat ion also provides repair and maintenance services; and custom services, such as cell line development, custom media modification, and primers and custom assays development services. Its products offer research tools for genomics studies, proteomics studies, gene splicing, cellular analysis, and other research applications required by laboratories associated with universities, medical research centers, and government and other research institutions, as well as biotechnology, pharmaceutical, and chemical companies; and serves clinical labs, medical institutions, medical researchers, and various industries through sales and service professionals, e-commerce capabilities, and onsite supply center solutions. The company was founded in 1987 and is headquartered in Carlsbad, California.
Advisors' Opinion:- [By Keith Speights]
Thermo Fisher Scientific (NYSE: TMO ) announced today that it will acquire genomics company Life Technologies (NASDAQ: LIFE ) in a $13.6 billion deal. The agreement calls for Thermo Fisher to pay $76 per diluted share, as well as assume around $2.2 billion in Life Technologies' debt.
- [By Sean Williams]
Two names worth considering here are Thermo Fisher Scientific (NYSE: TMO ) and Illumina (NASDAQ: ILMN ) . Thermo Fisher makes the list as it's in the process of purchasing Life Technologies (NASDAQ: LIFE ) for $13.6 billion. In early 2012, Life Technologies introduced the Benchtop Ion Proton Sequencer, which is capable of delivering same-day genome results for just $1,000! Illumina, on the other hand, has researchers' bases covered from all ends. It offers four high-end sequencing machines, a lower-priced sequencer (MiSeq), and can handle cloud-based data to formulate decoding. These two companies could be the cornerstone of nCoV research!
No comments:
Post a Comment